Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Immune and Anticancer Responses Elicited by Fully Synthetic Aberrantly Glycosylated MUC1 Tripartite Vaccines Modified by a TLR2 or TLR9 Agonist
Authors
Keywords
-
Journal
CHEMBIOCHEM
Volume 15, Issue 10, Pages 1508-1513
Publisher
Wiley
Online
2014-05-31
DOI
10.1002/cbic.201402077
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthesis and Immunological Evaluation of a MUC1 Glycopeptide Incorporated into l-Rhamnose Displaying Liposomes
- (2013) Sourav Sarkar et al. BIOCONJUGATE CHEMISTRY
- The development of synthetic antitumour vaccines from mucin glycopeptide antigens
- (2013) Nikola Gaidzik et al. CHEMICAL SOCIETY REVIEWS
- Intratumoral delivery of CpG-conjugated anti-MUC1 antibody enhances NK cell anti-tumor activity
- (2012) Jorge Schettini et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Synthesis and Immunological Evaluation of Self-Assembling and Self-Adjuvanting Tricomponent Glycopeptide Cancer-Vaccine Candidates
- (2012) Brendan L. Wilkinson et al. CHEMISTRY-A EUROPEAN JOURNAL
- Vaccine-Induced Effector-Memory CD8+ T Cell Responses Predict Therapeutic Efficacy against Tumors
- (2012) S. van Duikeren et al. JOURNAL OF IMMUNOLOGY
- Design of Fully Synthetic, Self-Adjuvanting Vaccine Incorporating the Tumor-Associated Carbohydrate Tn Antigen and Lipoamino Acid-Based Toll-like Receptor 2 Ligand
- (2012) Abu-Baker M. Abdel-Aal et al. JOURNAL OF MEDICINAL CHEMISTRY
- a Totally Synthetic, Self-Assembling, Adjuvant-Free MUC1 Glycopeptide Vaccine for Cancer Therapy
- (2012) Zhi-Hua Huang et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival
- (2012) Steffen Walter et al. NATURE MEDICINE
- TLR2 ligation protects effector T cells from regulatory T-cell mediated suppression and repolarizes T helper responses following MVA-based cancer immunotherapy
- (2012) Laurent Amiset et al. OncoImmunology
- Carbohydrate-Monophosphoryl Lipid A Conjugates Are Fully Synthetic Self-Adjuvanting Cancer Vaccines Eliciting Robust Immune Responses in the Mouse
- (2011) Qianli Wang et al. ACS Chemical Biology
- TLR1/TLR2 Agonist Induces Tumor Regression by Reciprocal Modulation of Effector and Regulatory T Cells
- (2011) Y. Zhang et al. JOURNAL OF IMMUNOLOGY
- Immune recognition of tumor-associated mucin MUC1 is achieved by a fully synthetic aberrantly glycosylated MUC1 tripartite vaccine
- (2011) V. Lakshminarayanan et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Analysis of a cholera toxin B subunit (CTB) and human mucin 1 (MUC1) conjugate protein in a MUC1-tolerant mouse model
- (2010) Julia Pinkhasov et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- MUC1 immunotherapy
- (2010) Richard E Beatson et al. Immunotherapy
- Linear and Branched Glyco-Lipopeptide Vaccines Follow Distinct Cross-Presentation Pathways and Generate Different Magnitudes of Antitumor Immunity
- (2010) Olivier Renaudet et al. PLoS One
- Targeting of antigens to B cells augments antigen-specific T-cell responses and breaks immune tolerance to tumor-associated antigen MUC1
- (2008) C. Ding et al. BLOOD
- Toll-like receptor agonists and invariant natural killer T-cells enhance antibody-dependent cell-mediated cytotoxicity (ADCC)
- (2008) María Moreno et al. CANCER LETTERS
- Identification of O-glycosylated decapeptides within the MUC1 repeat domain as potential MHC class I (A2) binding epitopes
- (2008) Tanja Ninkovic et al. MOLECULAR IMMUNOLOGY
- Engagement of TLR signaling as adjuvant: Towards smarter vaccine and beyond
- (2008) Amit Lahiri et al. VACCINE
- Mucin-type O-glycosylation and its potential use in drug and vaccine development
- (2007) Mads Agervig Tarp et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started